Minimise transmission risk of CJD and vCJD in healthcare settings

Source: DHSC –Updated: 18 November 2021, Change made: Updated part 3: ‘Laboratory containment and control measures’.

Guidance produced by the ACDP TSE risk management subgroup aims to help minimise the risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) in healthcare and other work settings. Click here for the source guidance.